Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
about
PML promotes MHC class II gene expression by stabilizing the class II transactivatorEvidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1The function, regulation and therapeutic implications of the tumor suppressor protein, PMLPML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor poolSUMO interaction motifs in Sizn1 are required for promyelocytic leukemia protein nuclear body localization and for transcriptional activationPolymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.The tumor suppressor PML specifically accumulates at RPA/Rad51-containing DNA damage repair foci but is nonessential for DNA damage-induced fibroblast senescence.Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells.HO-1, RET and PML as possible markers for risk stratification of acute myelocytic leukemia and prognostic evaluation.PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapiesNuclear microenvironment in cancer diagnosis and treatmentImmunohistochemical expression of promyelocytic leukemia body in soft tissue sarcomasPromyelocytic leukemia protein induces apoptosis due to caspase-8 activation via the repression of NFkappaB activation in glioblastoma.Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.Progressive multifocal leukoencephalopathy and promyelocytic leukemia nuclear bodies: a review of clinical, neuropathological, and virological aspects of JC virus-induced demyelinating diseaseRole of the promyelocytic leukaemia protein in cell death regulation.PML Degradation: Multiple Ways to Eliminate PML.Induction of the pro-myelocytic leukaemia gene by type I and type II interferonsPML: An emerging tumor suppressor and a target with therapeutic potential.ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.PML: Regulation and multifaceted function beyond tumor suppression.Multimodal Light Microscopy Approaches to Reveal Structural and Functional Properties of Promyelocytic Leukemia Nuclear Bodies.
P2860
Q24299467-0F68C976-81F1-4136-BA11-3168AE1B19C5Q24316222-1DAF16CC-3883-4191-94B5-1D36662C89F7Q26779358-F109D3BE-7623-4F6B-96D1-054E6D51BA86Q28590200-4B841B20-27D5-47E4-8B63-7036C551D5E5Q28592859-626D325F-15D9-4366-8328-06B5EE1A7B4DQ33764157-A1CCAA86-6505-428B-9F36-FF5DB0B51F00Q33815705-8E6B9ED8-112B-4634-B168-F84CD07916AEQ35116715-312C3C50-8802-49E7-B4D3-388F0CB1524AQ36137373-34D040CD-05C2-4C3A-BBFF-1E2315B3CBF3Q36336147-ACD12028-BBE3-4E43-BD8F-D94CA0F8B8F0Q36693019-344015BA-7F2A-45C6-A56D-2E179384440EQ36810080-FAA757A6-75D5-4C78-884F-1A9F9527A2A6Q37032428-46F26E39-A6CD-41F4-AA45-A752DA2AD44CQ37284294-64797951-2E5E-4B05-956D-F865AEC941CDQ37721763-A529B077-BAF5-428B-BA91-2F0095389A1BQ37750534-E73E85F6-4493-4914-84E2-8FD1A522FB59Q37975087-409B2469-74CD-4C0B-9D93-F45FB04A9749Q38092800-999105B1-F9FF-4C32-A4C8-D1AC6BA3E128Q41824767-C7C2091C-D7CF-4BD6-99F0-ACA7088F6925Q41971647-FF984370-09FA-4617-8AE0-438800795115Q42850888-D36ED2F3-B78B-4C62-8C2C-FB139B5608BAQ49309753-26CCF0C6-1B42-4FE6-80F8-D24B86BF20B0Q54962816-6CABDABB-2D0E-4C93-B175-9E352634BFD3
P2860
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Heterogeneous nuclear expressi ...... and neoplastic human tissues.
@ast
Heterogeneous nuclear expressi ...... and neoplastic human tissues.
@en
type
label
Heterogeneous nuclear expressi ...... and neoplastic human tissues.
@ast
Heterogeneous nuclear expressi ...... and neoplastic human tissues.
@en
prefLabel
Heterogeneous nuclear expressi ...... and neoplastic human tissues.
@ast
Heterogeneous nuclear expressi ...... and neoplastic human tissues.
@en
P2093
P2860
P1476
Heterogeneous nuclear expressi ...... l and neoplastic human tissues
@en
P2093
A Mencarelli
L Leoncini
L Pasqualucci
M Gambacorta
P2860
P304
P407
P577
1996-12-01T00:00:00Z